XML 126 R111.htm IDEA: XBRL DOCUMENT v3.25.2
Restatement of Quarterly Financial Information (Unaudited) - Schedule of Restated Condensed Consolidated Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Operating Activities:              
Net loss     $ 1,996 $ (6,326) $ 2,410 $ (7,198) $ (82,817)
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Non-cash lease expense     199 362 561 765 824
Depreciation and amortization     367 564 778 997 746
Stock-based compensation     552 1,357 2,217 3,056 8,357
Provision for uncollectible accounts         1,065 1,418 12,675
Unrealized exchange (gain) or loss     314 373 (29) 594 (180)
Provision for inventory     209 369 1,052 2,228 1,399
Change in fair value of warrant liabilities     (3,131) (4,507) (14,210) (17,024) (8,364)
Change in fair value of derivative liabilities     62 (1,895) (1,895) (1,895) 1,730
Change in fair value of Revenue Interest Financing and PIPE Conversion Option $ (496) $ 5,994 2,100 8,094 7,598 4,771 4,402
Change in fair value of earn-out liabilities (2,260) (5,690) (14,190) (19,880) (22,140) (22,900) (29,050)
Interest paid on debt recorded at fair value       (1,054) (2,458) (3,098) (1,092)
Change in fair value of debt       (8,070) (16,000) (18,090) 3,751
Debt issuance costs associated with debt recorded at fair value       1,357 1,357 1,357 1,210
Non-cash interest expense     315 1,464 1,464 1,464 2,083
Non-cash termination of convertible note side letters             16,098
Loss on extinguishment of debt/ term loan   8,713   8,713 8,713 8,713 3,929
Issuance costs associated with warrants recorded at fair value         942 942  
Changes in operating assets and liabilities:              
Accounts receivable     1,673 4,412 7,199 8,977 (1,318)
Inventory     330 1,014 551 543 (3,705)
Prepaid expenses, other current and long-term assets     244 718 747 913 285
Lease liabilities     (238) (411) (593) (836) (789)
Accounts payable     1,551 (2,504) (578) (3,924) 4,664
Accrued expenses and other current liabilities     (989) (1,713) (7,777) (4,073) 1,057
Net cash used in operating activities     (8,636) (17,563) (29,026) (42,300) (63,982)
Investing Activities:              
Purchases of property and equipment     (104) (539) (611) (611) (1,606)
Net cash used in investing activities     (104) (539) (611) (611) (1,606)
Financing Activities:              
Proceeds from issuance of convertible notes       48,000 48,000 48,000 28,700
Proceeds from Term Loan - net             59,780
Proceeds from Business Combination, net of transaction costs             61,652
Proceeds from Revenue Interest Financing             40,000
Proceeds from option and warrant exercises     9 26 26 26 213
Proceeds from equity line financing     378 378 378 1,007  
Repayment of convertible notes             (10,750)
Proceeds from Private Placement, net of issuance costs         2,685 2,592  
Proceeds from Public Offering, net of issuance costs         18,249 17,660  
Payment of debt issuance costs       (1,357) (1,357) (1,357) (3,450)
Repayment of promissory note assumed in Business Combination             (2,500)
Net cash provided by (used in) financing activities     387 (673) 20,261 20,208 95,986
Net increase (decrease) in cash and cash equivalents and restricted cash     (8,353) (18,775) (9,376) (22,703) 30,398
Cash and cash equivalents and restricted cash at beginning of period 19,646 30,068 38,421 38,421 38,421 38,421 8,023
Cash and cash equivalents and restricted cash at end of period 29,045 19,646 30,068 19,646 29,045 15,718 38,421
Supplemental disclosure of cash flow information              
Cash paid for interest     1,831 2,672 2,672 2,672 8,035
Supplemental cash flow information on non-cash investing and financing activities              
Purchase of property and equipment included in accounts payable     73 31     134
Deferred financing costs in accounts payable and accrued expenses       1,207 1,004 323 580
Change in fair value of Revenue Interest Financing through OCI     2,200 5,200 (600) (4,370) 700
Recognition of assumed warrant liability             13,762
Recognition of earn-out liabilities             53,040
Issuance of common stock upon conversion of convertible notes             25,569
Change in fair value of RTW Convertible Notes through other comprehensive income       80 (2,990) (4,700)  
2021 Term Loan              
Financing Activities:              
Repayment of term loan             (57,659)
Fortress Term Loan              
Financing Activities:              
Repayment of term loan       (47,720) (47,720) (47,720) (20,000)
As Reported              
Operating Activities:              
Net loss     5,586 3,424 (5,580) (26,148) (80,607)
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Non-cash lease expense     199 362 561 765 824
Depreciation and amortization     367 564 778 997 746
Stock-based compensation     552 1,357 2,217 3,056 8,357
Provision for uncollectible accounts         1,065 1,418 12,675
Unrealized exchange (gain) or loss     314 373 (29) 594 (180)
Provision for inventory     209 369 1,052 2,228 1,399
Change in fair value of warrant liabilities     (3,131) (4,507) (14,210) (17,024) (8,364)
Change in fair value of derivative liabilities     62 (1,895) (1,895) (1,895) 1,730
Change in fair value of Revenue Interest Financing and PIPE Conversion Option 11,104 (6) (1,490) (1,496) 9,608 14,321 2,192
Change in fair value of earn-out liabilities (2,260) (5,690) (14,190) (19,880) (22,140) (22,900) (29,050)
Interest paid on debt recorded at fair value       (1,054) (2,458) (3,098) (1,092)
Change in fair value of debt       (8,230) (10,020) (8,690) 3,751
Debt issuance costs associated with debt recorded at fair value       1,357 1,357 1,357 1,210
Non-cash interest expense     315 1,464 1,464 1,464 2,083
Non-cash termination of convertible note side letters             16,098
Loss on extinguishment of debt/ term loan   8,713   8,713 8,713 8,713 3,929
Issuance costs associated with warrants recorded at fair value         942 942  
Changes in operating assets and liabilities:              
Accounts receivable     1,673 4,412 7,199 8,977 (1,318)
Inventory     330 1,014 551 543 (3,705)
Prepaid expenses, other current and long-term assets     244 718 747 913 285
Lease liabilities     (238) (411) (593) (836) (789)
Accounts payable     1,551 (2,504) (578) (3,924) 4,664
Accrued expenses and other current liabilities     (989) (1,713) (7,777) (4,073) 1,057
Net cash used in operating activities     (8,636) (17,563) (29,026) (42,300) (63,982)
Investing Activities:              
Purchases of property and equipment     (104) (539) (611) (611) (1,606)
Net cash used in investing activities     (104) (539) (611) (611) (1,606)
Financing Activities:              
Proceeds from issuance of convertible notes       48,000 48,000 48,000 28,700
Proceeds from Term Loan - net             59,780
Proceeds from Business Combination, net of transaction costs             61,652
Proceeds from Revenue Interest Financing             40,000
Proceeds from option and warrant exercises     9 26 26 26 213
Proceeds from equity line financing     378 378 378 1,007  
Repayment of convertible notes             (10,750)
Proceeds from Private Placement, net of issuance costs         2,685 2,592  
Proceeds from Public Offering, net of issuance costs         18,249 17,660  
Payment of debt issuance costs       (1,357) (1,357) (1,357) (3,450)
Repayment of promissory note assumed in Business Combination             (2,500)
Net cash provided by (used in) financing activities     387 (673) 20,261 20,208 95,986
Net increase (decrease) in cash and cash equivalents and restricted cash     (8,353) (18,775) (9,376) (22,703) 30,398
Cash and cash equivalents and restricted cash at beginning of period 19,646 30,068 38,421 38,421 38,421 38,421 8,023
Cash and cash equivalents and restricted cash at end of period 29,045 19,646 30,068 19,646 29,045 15,718 38,421
Supplemental disclosure of cash flow information              
Cash paid for interest     1,831 2,672 2,672 2,672 8,035
Supplemental cash flow information on non-cash investing and financing activities              
Purchase of property and equipment included in accounts payable     73 31     134
Deferred financing costs in accounts payable and accrued expenses       1,207 1,004 323 580
Change in fair value of Revenue Interest Financing through OCI     (2,200) (5,280) 600 4,370 (700)
Recognition of assumed warrant liability             13,762
Recognition of earn-out liabilities             53,040
Issuance of common stock upon conversion of convertible notes             25,569
Change in fair value of RTW Convertible Notes through other comprehensive income         2,990 4,700  
As Reported | 2021 Term Loan              
Financing Activities:              
Repayment of term loan             (57,659)
As Reported | Fortress Term Loan              
Financing Activities:              
Repayment of term loan       (47,720) (47,720) (47,720) (20,000)
Adjustment              
Operating Activities:              
Net loss     (3,590) (9,750) 7,990 18,950 (2,210)
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Change in fair value of Revenue Interest Financing and PIPE Conversion Option $ (11,600) $ 6,000 3,590 9,590 (2,010) (9,550) 2,210
Change in fair value of debt       160 (5,980) (9,400)  
Supplemental cash flow information on non-cash investing and financing activities              
Change in fair value of Revenue Interest Financing through OCI     $ 4,400 10,480 (1,200) (8,740) $ 1,400
Change in fair value of RTW Convertible Notes through other comprehensive income       $ 80 $ (5,980) $ (9,400)